Se
Non vérifié

Seek Labs

Ce que nous écrivons

BiotechnologieIndustrieSantéScienceTechnique
17/11/2025
Industrie
Santé
VIH, SIDA et maladies auto-immunes
Technique
Industrie pharmaceutique
Biotechnologie
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever
1.00
21/10/2025
Santé
VIH, SIDA et maladies auto-immunes
Technique
Science
Biotechnologie
Industrie
Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™
1.00
07/10/2025
Santé
Technique
Santé Publique
Science
Biotechnologie
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™
1.00
24/09/2025
Marché du travail
Industrie
Science
Technique
Biotechnologie
Santé Publique
Industrie pharmaceutique
Santé
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)
1.00
09/09/2025
Vétérinaire
Agriculture
Biotechnologie
Matières premières
Industrie pharmaceutique
Santé
VIH, SIDA et maladies auto-immunes
Industrie
Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic
1.00
13/08/2025
Science
Santé Publique
Industrie pharmaceutique
Technique
Équipement médical et sanitaire
VIH, SIDA et maladies auto-immunes
Médecine - Divers
Biotechnologie
Santé
Événements
Expos
Industrie
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform
1.00
05/08/2025
Science
Technique
VIH, SIDA et maladies auto-immunes
Biotechnologie
Santé Publique
Santé
Industrie
Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™, Accelerating Therapeutic Discovery for Chikungunya, West Nile Virus, and Zika
1.00
08/07/2025
Logiciels
Science
Santé Publique
Industrie pharmaceutique
Technologies de l'Information
Technique
VIH, SIDA et maladies auto-immunes
Biotechnologie
Santé
Industrie
Seek Labs’ BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
1.00
23/06/2025
Santé
Technique
Biotechnologie
Industrie pharmaceutique
Industrie
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0